NFE2L2 and benign prostatic hyperplasia: Compared to the Con group, the expression of androgen signaling, growth factors, and inflammatory factors such as Cox-2 and iNOS, was upregulated in the BPH group, whereas the expression of Nrf-2 and HO-1 was downregulated.